Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of JK1211 (Itraconazole) in Systemic Fungal Infection and Febrile Neutropenia
NCT00784368Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2008
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of itraconazole in systemic mycosis, febrile neutropenia (FN), candidiasis, aspergillosis, cryptococcosis, sponsored by Janssen Pharmaceutical. Started Jan 2008; status: completed.
02
Drugs
itraconazole
03
Conditions
systemic mycosisfebrile neutropenia (FN)candidiasisaspergillosiscryptococcosis
Beyond the preview
Go deeper on NCT00784368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784368.